SMTL ID : 4d7g.1

Human FXIa in complex with small molecule inhibitors.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.33 Å

Oligo State

monomer

Ligands

6 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 3 residues within 4Å: Chain A: R.26, L.28 Ligands: E6U.7 No protein-ligand interaction detected (PLIP) GOL.2: 5 residues within 4Å: Chain A: H.44, S.207, W.208, G.209 Ligands: E6U.7 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:S.207, A:G.209, A:G.209 Water bridges: A:H.44 GOL.3: 5 residues within 4Å: Chain A: E.11, K.195, W.200 Ligands: GOL.4, GOL.6 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:E.11, A:K.195, A:K.195 GOL.4: 7 residues within 4Å: Chain A: E.11, W.12, D.126, W.128, K.147, W.200 Ligands: GOL.3 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:K.147 GOL.5: 5 residues within 4Å: Chain A: H.19, R.26, H.27, Q.64 Ligands: E6U.7 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:H.27 GOL.6: 4 residues within 4Å: Chain A: E.11, P.13, R.110 Ligands: GOL.3 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:E.11, A:R.110, A:R.110

1 x E6U: N-[(1S)-1-benzyl-2-(3-guanidinopropylamino)-2-oxo-ethyl]-4-hydroxy-2-oxo-1H-quinoline-6-carboxamide

E6U.7: 23 residues within 4Å: Chain A: R.26, H.27, L.28, C.29, H.44, Y.134, I.141, D.182, A.183, C.184, K.185, G.186, D.187, S.188, T.206, S.207, W.208, G.209, G.211, G.219 Ligands: GOL.1, GOL.2, GOL.5 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:L.28, A:I.141 Hydrogen bonds: A:H.27, A:G.186, A:D.187, A:S.188, A:G.211 Water bridges: A:K.185, A:G.186, A:S.188, A:W.208, A:Y.221 Salt bridges: A:D.182

5 x SO4: SULFATE ION(Non-functional Binders)

SO4.8: 2 residues within 4Å: Chain A: K.117, R.120 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:K.117, A:R.120 SO4.9: 4 residues within 4Å: Chain A: G.4, T.5, A.6, Q.146 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:A.6, A:Q.146, A:Q.146 SO4.10: 3 residues within 4Å: Chain A: Y.176, R.177, E.178 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:R.177, A:E.178 SO4.11: 2 residues within 4Å: Chain A: K.117, R.120 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:R.120 SO4.12: 1 residues within 4Å: Chain A: N.121 No protein-ligand interaction detected (PLIP)

1 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)

TRS.13: 0 residues within 4Å: (No contacts) No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Jacso, T. et al., From Mm Fragments to Nm Compounds Using Iloe-NMR to Guide Linking of Compounds in Fragment Based Drug Discovery (Fbdd). To be Published

Release Date

2016-01-20

Peptides

COAGULATION FACTOR XIA: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

COAGULATION FACTOR XIA

Related Entries With Identical Sequence